One CRISPR Infusion Cut Triglycerides 63% in 10 Adults With Diabetes and Severe Levels in Small Early Trial
A single experimental CTX310 infusion lowered triglycerides by 63% after 30 days in 10 adults with severe hypertriglyceridemia, though longer and larger studies are needed.
Medical Daily ·